Related Experiment Video
Updated: Oct 16, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
Cytochrome c is involved in Fas-mediated apoptosis of prostatic carcinoma cell lines
A Gewies1, O W Rokhlin, M B Cohen
1Department of Pathology, University of Iowa, Iowa City 52242, USA.
Abstract:
We have shown previously that the pathways leading to Fas-mediated apoptosis in prostatic carcinoma cell lines are intact, because apoptosis can be triggered either by Fas ligation alone in the Fas-sensitive cell lines PC3 and ALVA31 or by rendering the Fas-resistant cell lines DU145 and JCA1 Fas-sensitive by combined treatment with anti-Fas monoclonal antibody and cycloheximide (O. W. Rokhlin et al., Cancer Res., 57: 1758-1768, 1997). In this study, we demonstrate that two of the early events after Fas ligation are the release of cytochrome c from the mitochondria and activation of caspase-9. We also found that Bid is processed after Fas ligation and thus might activate the mitochondria-dependent apoptotic cascade. In a cell-free system, cytochrome c induced caspase-3-like activity in cytoplasmic extracts from all four cell lines studied, although differences in the level of enzymatic activity were observed. Western blot analysis revealed that caspase-7 is activated by cytochrome c at the same level in all extracts, whereas expression and activation of caspase-3 varied considerably. Cytochrome c-activated extracts displayed different abilities in the induction of apoptotic features in isolated nuclei such as morphological changes and DNA fragmentation. However, differences in nuclear apoptotic activity induced by cytochrome c did not correlate with the level of caspase-3 like activity in the different extracts. These results suggest that the mitochondrial pathway is involved in Fas-mediated apoptosis in prostatic carcinoma cell lines and that, in addition to caspase-7 and caspase-3, there are other factors that confer nuclear apoptotic activity.
Insights
Fas-mediated apoptosis in prostate cancer cells involves mitochondrial pathways. Cytochrome c release and caspase activation are key, but other factors influence nuclear apoptosis.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Death Pathways
Background:
- Prostatic carcinoma cell lines possess intact Fas-mediated apoptosis pathways.
- Fas-sensitive and Fas-resistant cell lines respond to Fas ligation with or without cycloheximide treatment.
Purpose of the Study:
- To investigate early events in Fas-mediated apoptosis in prostate cancer.
- To elucidate the role of the mitochondrial pathway and caspases in this process.
Main Methods:
- Fas ligation in prostate cancer cell lines.
- Analysis of cytochrome c release, caspase activation (caspase-9, caspase-3, caspase-7), and Bid processing.
- Cell-free system assays using cytoplasmic extracts and isolated nuclei.
Main Results:
- Fas ligation triggers cytochrome c release from mitochondria and caspase-9 activation.
- Bid processing suggests activation of the mitochondria-dependent apoptotic cascade.
- Cytochrome c induces caspase-3-like activity and caspase-7 activation in all cell lines, but caspase-3 expression and activation vary.
- Nuclear apoptotic activity induced by cytochrome c does not solely correlate with caspase-3 levels.
Conclusions:
- The mitochondrial pathway is implicated in Fas-mediated apoptosis in prostate cancer.
- Factors beyond caspase-3 and caspase-7 contribute to nuclear apoptotic activity in these cells.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Caspases
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
Anaphase Promoting Complex

